Alpha Tau Medical (DRTS) Gains from Investment Securities (2020 - 2025)

Alpha Tau Medical has disclosed Gains from Investment Securities across 6 years of filings, most recently posting $11.0 million for Q4 2025.

• Gains from Investment Securities for Q4 2025 came in at $11.0 million, up 163.15% year-over-year; the trailing twelve-month figure through Dec 2025 was $11.0 million (up 163.15% YoY), and the FY2025 annual result was $11.0 million, up 163.15% from the prior year.
• Gains from Investment Securities came in at $11.0 million for Q4 2025 at Alpha Tau Medical, up from $4.2 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $11.0 million in Q4 2025 to a low of $40000.0 in Q1 2021.
• The 5-year median for Gains from Investment Securities is $4.7 million (2021), against an average of $5.0 million.
• Across the five-year window, Gains from Investment Securities tumbled 85.51% in 2023 and soared 249.4% in 2024, its largest moves.
• Alpha Tau Medical's Gains from Investment Securities stood at $5.3 million in 2021, then soared by 54.68% to $8.2 million in 2022, then sank by 85.51% to $1.2 million in 2023, then jumped by 249.4% to $4.2 million in 2024, then jumped by 163.15% to $11.0 million in 2025.
• The last three Gains from Investment Securities figures came in at $11.0 million (Q4 2025), $4.2 million (Q4 2024), and $1.2 million (Q4 2023), per Business Quant data.